Myfortic (360mg) 120 Tablets
Mycophenolate sodium 360mg tablets for organ transplant rejection prevention.
Myfortic 360mg contains mycophenolate sodium, an immunosuppressive agent used to prevent the body from rejecting a transplanted kidney. It works by inhibiting the enzyme inosine monophosphate dehydrogenase, which is necessary for the proliferation of T and B lymphocytes that lead to organ rejection. It is used as part of a multi-drug regimen.
Purpose
Prophylaxis of organ rejection in patients receiving allogeneic renal transplants.
Ingredients
Mycophenolate sodium 360mg (equivalent to 333mg mycophenolic acid).
Warnings
High risk of miscarriage and birth defects; use effective contraception. Increases susceptibility to serious infections.
Side Effects
Diarrhea, low white blood cell counts, infections, and nausea. Increased risk of certain cancers like lymphoma.
Storage Instructions
Store below 30°C in the original package to protect from moisture.
| Brand | Novartis |
| Status | Active |
Related Products
